QUEBEC, June 14, 2012 /CNW Telbec/ - Victhom Human Bionics Inc. ("Victhom") (TSXV: VHB) today reported the results of its Annual General Meeting of shareholders held in Montreal, Quebec on June 13, 2012.
The shareholders approved the motions put forth at the meeting to re-appoint the four directors of the Company: Daniel Johnson, Nitin Kaushal, Martin Leblanc and Normand Rivard and to appoint Ernst & Young LLP as the Company's auditors.
At their meeting held directly following the Annual General Meeting, the directors re-appointed Mr. Daniel Johnson as Chairman of the Board.
About Victhom
Victhom is a company which owns patents in the field of orthotics and prosthetics (O&P), including intellectual property used in the Power Knee, the world's first and only motor-powered prosthesis for above-knee amputees, a product distributed under license agreement by Ossur, a global leader in the O&P market. The Company also has a royalty agreement related to the Neurostep® System and neuromodulation products in other indications (sleep apnea and epilepsy) using the Neurobionix technology platform currently under development by Neurostream Technologies, a General Partnership now owned by Otto Bock, a global leader in the O&P market.
FORWARD-LOOKING STATEMENTS
Some of the statements made herein may constitute forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause Victhom's actual results, performance or achievements to be materially different from those expressed or implied by any of Victhom's statements. Actual events or results may differ materially. We disclaim any intention, and assume no obligation, to update these forward-looking statements.
Source:
Victhom Human Bionics Inc.
For more information:
Normand Rivard
President & CEO
Victhom Human Bionics Inc.
Tel.: 438-380-5244
Share this article